New medicine to reduce triglycerides in adults with familial chylomicronaemia syndrome

View source ↗

Summary

EMA announces a new medicine, Redemplo, to reduce triglycerides in adults with familial chylomicronaemia syndrome, offering a treatment option for a high unmet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Chylomicronaemia Syndrome

Drugs mentioned

• REDEMPLO (PLOZASIRAN)

Snippet

Redemplo provides new treatment option for patients with a high unmet medical need